Prostarm Board Approves ₹43.27 Crore Convertible Warrant Issue

Other Income Boosts Profits PAT at Rs 4.6 Cr in Q1 FY27 (consolidated), +150.5% YoY. Revenue at Rs 76.0 Cr in Q1 FY27 (consolidated), +38.5% YoY. EBITDA at Rs 9.0 Cr, +90.5% YoY; Other Income rose to Rs 2.5 Cr from Rs 0.8 Cr, +203% YoY. EBITDA margin at 11.9% vs 8.6%. Board proposed preferential issue of warrants worth Rs 43.3 Cr, approved alteration of the MOA and appointment of new statutory auditors. Commencement of relocated operations was delayed pending regulatory approval and is now expected by September 30, 2026.